Aurobindo Pharma Limited announced its participation in the Goldman Sachs India Pharma Corporate Days event. The meeting is scheduled to take place virtually on March 6, 2026, from 02:00 PM to 5:00 PM IST. Officials from the company will be attending this investor meeting. The schedule is subject to change due to exigencies on the part of the investor or the company. Aurobindo Pharma has confirmed that no unpublished price sensitive information (UPSI) will be discussed during these interactions. This event falls under the category of investor communications, allowing the company to engage with institutional investors and analysts.
